Loading...

Johnson & Johnson Ordered to Pay $572 Million for Role in State’s Opioid Epidemic

August 26, 2019 by Dan McCue
Johnson & Johnson Ordered to Pay $572 Million for Role in State’s Opioid Epidemic

An Oklahoma judge on Monday ordered Johnson & Johnson to pay $572 million for its role in fueling the state’s opioid abuse crisis.

Cleveland County District Judge Thad Balkman’s ruling concluded the first state opioid case to make it to trial.

In handing it down, he said “the opioid crisis has ravaged the state of Oklahoma. It must be abated immediately.”

“For this reason, I’m entering an abatement plan that consists of costs totaling $572,102,028 to immediately remediate the nuisance,” he said.

Johnson & Johnson and its subsidiaries are expected to appeal the ruling to the Oklahoma Supreme Court.

The outcome is expected to have broad implications for the more than 1,500 similar lawsuits filed by local, state and tribal governments that have been consolidated before a federal judge in Ohio.

With Balkman’s ruling, a judge, for the first time has said drug companies can be held liable for the national health crisis of opioid addiction.

Prior to the start of the Johnson & Johnson trial in late May, Oklahoma had reached settlements with two other defendants, with Oxycontin maker Purdue Parma agreeing to pay the state $270 million and Teva Pharmaceutical Industries Ltd. agreeing to pay $85 million.

In the underlying lawsuit, Oklahoma claimed the drug makers overstated how effective their products were for treating chronic pain and understated the risk of addiction.

According to the state Attorney General’s office, 4,653 residents of the state were killed by opioid overdoses between 2007 and 2017.

Oklahoma Attorney General Mike Hunter said on Twitter Monday morning that the state’s case revealed how “corporate greed got in the way of responsible practices at Johnson & Johnson.”

Attorneys for the company countered by arguing their clients did nothing illegal and that they are part of a heavily-regulated industry subject to strict oversight by a number of federal agencies. 

In The News

Health

Voting

Opioids

June 27, 2022
by Dan McCue
Justices Side With Two Doctors Snared in Opioid ‘Pill Mill’ Case 

WASHINGTON — In a unanimous ruling the Supreme Court said on Monday that prosecutors must prove doctors knowingly misprescribed drugs... Read More

WASHINGTON — In a unanimous ruling the Supreme Court said on Monday that prosecutors must prove doctors knowingly misprescribed drugs to secure convictions against them for the unlawful distribution of controlled medicines, like opioids. The decision came down in a case brought by two doctors, Xiulu... Read More

April 7, 2022
by Alexa Hornbeck
House Committee Examines Impact of Opioid Crisis on Tribal Communities  

WASHINGTON — This week the U.S. House Natural Resources Subcommittee on Oversight and Investigations held a hearing to discuss the... Read More

WASHINGTON — This week the U.S. House Natural Resources Subcommittee on Oversight and Investigations held a hearing to discuss the opioid crisis in tribal communities. “Opioid overdose deaths during the pandemic increased more in Native American communities than … for any other racial or ethnic group,”... Read More

Opioid Crisis Victims to Confront Purdue Pharma's Owners

NEW YORK (AP) — Their advocacy helped send Purdue Pharma into bankruptcy and is forcing the family that has controlled... Read More

NEW YORK (AP) — Their advocacy helped send Purdue Pharma into bankruptcy and is forcing the family that has controlled the company for generations to relinquish ownership and provide billions of dollars for communities to combat opioid addiction. But what victims of opioid abuse and those... Read More

Opioid Fight Needs New Strategy, Cabinet Leadership: Report

WASHINGTON (AP) — The U.S. needs a nimble, multipronged strategy and Cabinet-level leadership to counter its festering overdose epidemic, a... Read More

WASHINGTON (AP) — The U.S. needs a nimble, multipronged strategy and Cabinet-level leadership to counter its festering overdose epidemic, a bipartisan congressional commission advises. With vastly powerful synthetic drugs like fentanyl driving record overdose deaths, the scourge of opioids awaits after the COVID-19 pandemic finally recedes, a shift... Read More

January 31, 2020
by Tom Ramstack
Congress Weighs Options to Control Opioid Copycats

WASHINGTON -- Drug control experts urged Congress Tuesday to take quick action to prevent drugs created by clandestine chemists that... Read More

WASHINGTON -- Drug control experts urged Congress Tuesday to take quick action to prevent drugs created by clandestine chemists that mimic the effects of opioids from entering legal and illegal marketplaces. They suggested that Congress turn a temporary order on the chemicals into a permanent prohibition... Read More

December 20, 2019
by Tom Ramstack
Senate Grapples with Spiraling Opioid Epidemic

WASHINGTON -- A U.S. Senate committee sought answers again Tuesday on how to stop a nationwide crisis of opioid addictions... Read More

WASHINGTON -- A U.S. Senate committee sought answers again Tuesday on how to stop a nationwide crisis of opioid addictions while acknowledging their previous efforts have largely failed. A record 61,300 people died from drug overdoses in 2017 in the U.S., up from 54,800 a year... Read More

News From The Well